tradingkey.logo

Legend Biotech Corp

LEGN
31.700USD
-0.520-1.61%
Fechamento 10/10, 16:00ETCotações atrasadas em 15 min
5.85BValor de mercado
PerdaP/L TTM

Legend Biotech Corp

31.700
-0.520-1.61%

Mais detalhes de Legend Biotech Corp Empresa

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Informações de Legend Biotech Corp

Código da empresaLEGN
Nome da EmpresaLegend Biotech Corp
Data de listagemJun 04, 2020
CEODr. Ying Huang, Ph.D.
Número de funcionários2600
Tipo de títulosDepository Receipt
Fim do ano fiscalJun 04
Endereço2101 Cottontail Lane
CidadeSOMERSET
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal08873
Telefone17328505598
Sitehttps://investors.legendbiotech.com/
Código da empresaLEGN
Data de listagemJun 04, 2020
CEODr. Ying Huang, Ph.D.

Executivos da empresa Legend Biotech Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Ye (Sally) Wang
Ms. Ye (Sally) Wang
Director
Director
84.32K
--
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
7.62K
--
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Ms. Jessie Yeung
Ms. Jessie Yeung
Director
Director
--
--
Dr. Peter Salovey, Ph.D.
Dr. Peter Salovey, Ph.D.
Independent Director
Independent Director
--
--
Mr. Wai Man (Philip) Yau, CPA
Mr. Wai Man (Philip) Yau, CPA
Independent Director
Independent Director
--
--
Dr. Ying Huang, Ph.D.
Dr. Ying Huang, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
-100.00%
Mr. Tomas J. (Tom) Heyman, Jr.
Mr. Tomas J. (Tom) Heyman, Jr.
Independent Director
Independent Director
--
--
Dr. Fangliang (Frank) Zhang, Ph.D.
Dr. Fangliang (Frank) Zhang, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Ye (Sally) Wang
Ms. Ye (Sally) Wang
Director
Director
84.32K
--
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
7.62K
--
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Ms. Jessie Yeung
Ms. Jessie Yeung
Director
Director
--
--
Dr. Peter Salovey, Ph.D.
Dr. Peter Salovey, Ph.D.
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
194.60M
76.30%
Europe
40.50M
15.88%
China
19.95M
7.82%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sex, 26 de set
Atualizado em: sex, 26 de set
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.53%
Westfield Capital Management Company, L.P.
3.51%
HHLR Advisors, Ltd.
3.36%
Suvretta Capital Management, LLC
2.04%
Deerfield Management Company, L.P.
1.60%
Outro
76.95%
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.53%
Westfield Capital Management Company, L.P.
3.51%
HHLR Advisors, Ltd.
3.36%
Suvretta Capital Management, LLC
2.04%
Deerfield Management Company, L.P.
1.60%
Outro
76.95%
Tipos de investidores
Investidores
Proporção
Investment Advisor
22.83%
Investment Advisor/Hedge Fund
13.71%
Hedge Fund
8.80%
Corporation
1.22%
Research Firm
1.12%
Venture Capital
0.59%
Pension Fund
0.37%
Bank and Trust
0.31%
Sovereign Wealth Fund
0.20%
Outro
50.86%

Participação acionária institucional

Atualizado em: dom, 5 de out
Atualizado em: dom, 5 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
544
88.77M
48.09%
-19.63M
2025Q2
545
89.45M
48.54%
-25.68M
2025Q1
566
91.15M
49.68%
-26.78M
2024Q4
546
104.37M
56.89%
-4.12M
2024Q3
521
96.19M
52.43%
-11.10M
2024Q2
501
96.66M
52.77%
-1.31M
2024Q1
490
91.55M
50.22%
-3.47M
2023Q4
482
91.08M
50.06%
-4.11M
2023Q3
468
90.50M
49.93%
-2.81M
2023Q2
459
88.99M
49.23%
+9.84M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
23.13M
12.53%
+11.87M
+105.49%
Jun 30, 2025
Westfield Capital Management Company, L.P.
6.47M
3.51%
-445.02K
-6.43%
Jun 30, 2025
HHLR Advisors, Ltd.
6.20M
3.36%
+218.70K
+3.65%
Jun 30, 2025
Suvretta Capital Management, LLC
3.77M
2.04%
+24.04K
+0.64%
Jun 30, 2025
Deerfield Management Company, L.P.
2.96M
1.6%
+1.22M
+69.90%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.85M
1.55%
-255.88K
-8.23%
Jun 30, 2025
Braidwell LP
2.54M
1.38%
-435.85K
-14.64%
Jun 30, 2025
Fidelity Institutional Asset Management
2.54M
1.38%
+593.12K
+30.44%
Jun 30, 2025
Genscript Biotech Corp
2.25M
1.22%
--
--
Dec 31, 2024
Artisan Partners Limited Partnership
2.12M
1.15%
+990.50K
+87.52%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: seg, 6 de out
Atualizado em: seg, 6 de out
Nome
Proporção
Harbor Health Care ETF
5.9%
Matthews Emerging Markets Discovery Active ETF
4.6%
Matthews Emerging Markets Sustainable Future Active ETF
4.43%
Global X Genomics & Biotechnology ETF
3.69%
Tema Oncology ETF
2.56%
Virtus LifeSci Biotech Products ETF
1.53%
KraneShares MSCI All China Health Care Index ETF
1.25%
Main Thematic Innovation ETF
0.46%
iShares Biotechnology ETF
0.39%
Invesco Nasdaq Biotechnology ETF
0.29%
Ver Mais
Harbor Health Care ETF
Proporção5.9%
Matthews Emerging Markets Discovery Active ETF
Proporção4.6%
Matthews Emerging Markets Sustainable Future Active ETF
Proporção4.43%
Global X Genomics & Biotechnology ETF
Proporção3.69%
Tema Oncology ETF
Proporção2.56%
Virtus LifeSci Biotech Products ETF
Proporção1.53%
KraneShares MSCI All China Health Care Index ETF
Proporção1.25%
Main Thematic Innovation ETF
Proporção0.46%
iShares Biotechnology ETF
Proporção0.39%
Invesco Nasdaq Biotechnology ETF
Proporção0.29%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI